Abstract
<div class="line" id="line-5"> We performed a double‐blind randomized placebo‐controlled pilot study to determine the efficacy of tegaserod (Zelnorm) in treating constipation in 15 patients with Parkinson's disease (PD). There was a trend for improvement in the Subject's Global Assessment (SGA) of satisfaction with bowel habits (NS) and the total SGA (including abdominal discomfort, bothersome constipation, and satisfaction; NS).</div>
Original language | American English |
---|---|
Journal | Movement Disorders |
Volume | 21 |
DOIs | |
State | Published - Jan 21 2006 |
Disciplines
- Public Health
Keywords
- Parkinson's Disease
- Tegaerod
- Zelnorm